About Exagen
Exagen is a company based in Vista (United States) founded in 2002. It operates as a HealthTech, and Professional Services. Exagen has raised $110.23 million across 36 funding rounds from investors including Sun Mountain Capital, HIG BioHealth Partners and Innovatus Capital Partners. The company has 209 employees as of December 31, 2024. Exagen offers products and services including AVISE CTD, AVISE Lupus, AVISE SLE Monitor, AVISE SLE Prognostic, and AVISE APS. Exagen operates in a competitive market with competitors including HYCOR BioMedical, Kypha, Lophius Biosciences, SmartHealth and TBG Diagnostics, among others.
- Headquarter Vista, United States
- Employees 209 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Exagen Inc.
-
Annual Revenue
$55.64 M5.89as on Dec 31, 2024
-
Net Profit
$-15.12 M36.19as on Dec 31, 2024
-
EBITDA
$-11.91 M42.37as on Dec 31, 2024
-
Total Equity Funding
$110.23 M (USD)
in 36 rounds
-
Latest Funding Round
$22.6 M (USD), Series C
Jul 16, 2019
-
Investors
Sun Mountain Capital
& 7 more
-
Employee Count
209
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Exagen
Exagen is a publicly listed company on the NASDAQ with ticker symbol XGN in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Exagen
Exagen offers a comprehensive portfolio of products and services, including AVISE CTD, AVISE Lupus, AVISE SLE Monitor, AVISE SLE Prognostic, and AVISE APS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Testing for SLE and connective tissue diseases is provided.
Diagnostic testing for systemic lupus erythematosus is offered.
Monitoring of systemic lupus erythematosus disease is conducted.
Prognostic testing for systemic lupus erythematosus is available.
Testing for antiphospholipid syndrome is provided to patients.
Unlock access to complete
Unlock access to complete
Funding Insights of Exagen
Exagen has successfully raised a total of $110.23M across 36 strategic funding rounds. The most recent funding activity was a Series C round of $22.6 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 36
- Last Round Series C — $22.6M
-
First Round
First Round
(01 Jan 2004)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2019 | Amount | Series C - Exagen | Valuation | HIG BioHealth Partners |
|
| Feb, 2019 | Amount | Series C - Exagen | Valuation |
investors |
|
| Sep, 2017 | Amount | Debt – Conventional - Exagen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Exagen
Exagen has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Sun Mountain Capital, HIG BioHealth Partners and Innovatus Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified debt funding is provided for growth capital opportunities.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on multiple sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Exagen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Exagen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Exagen Comparisons
Competitors of Exagen
Exagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Kypha, Lophius Biosciences, SmartHealth and TBG Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| domain | founded_year | HQ Location |
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
T-cell-based diagnostics for infectious and immune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostics for vascular, metabolic, and oncological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics kits, instruments, and software are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Exagen
Frequently Asked Questions about Exagen
When was Exagen founded?
Exagen was founded in 2002 and raised its 1st funding round 2 years after it was founded.
Where is Exagen located?
Exagen is headquartered in Vista, United States. It is registered at Vista, California, United States.
Is Exagen a funded company?
Exagen is a funded company, having raised a total of $110.23M across 36 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $25M, raised on Jan 01, 2004.
How many employees does Exagen have?
As of Dec 31, 2024, the latest employee count at Exagen is 209.
What is the annual revenue of Exagen?
Annual revenue of Exagen is $55.64M as on Dec 31, 2024.
What does Exagen do?
Exagen Inc. is engaged in providing advanced diagnostic, prognostic, and monitoring testing for autoimmune conditions. The company operates in the healthcare sector, specializing in rheumatology and lupus biomarkers. Solutions are developed to aid physicians in accurate and timely diagnosis and management of autoimmune diseases. Testing services like AVISE CTD, AVISE Lupus, and others are offered to improve patient outcomes through next-generation insights. Partnerships with biopharma and clinical trial support are also maintained to enhance research and development efforts.
Who are the top competitors of Exagen?
Exagen's top competitors include SmartHealth, HYCOR BioMedical and Lophius Biosciences.
What products or services does Exagen offer?
Exagen offers AVISE CTD, AVISE Lupus, AVISE SLE Monitor, AVISE SLE Prognostic, and AVISE APS.
Is Exagen publicly traded?
Yes, Exagen is publicly traded on NASDAQ under the ticker symbol XGN.
Who are Exagen's investors?
Exagen has 8 investors. Key investors include Sun Mountain Capital, HIG BioHealth Partners, Innovatus Capital Partners, Cottonwood Technology Fund, and CRG.
What is Exagen's ticker symbol?
The ticker symbol of Exagen is XGN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.